HEALTHSOUTH CORP
S-3, 1997-04-28
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: REFLECTONE INC /FL/, SC 13E3/A, 1997-04-28
Next: CENTURY BANCSHARES INC, DEF 14A, 1997-04-28




    AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 25, 1997
                                                     REGISTRATION NO. 333-
================================================================================
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                                   FORM S-3
           REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                   ----------
                           HEALTHSOUTH CORPORATION
              (Exact Name of Registrant as Specified in its Charter)
                                   ----------
<TABLE>
<CAPTION>
<S>                                  <C>                              <C>
     DELAWARE                                 8062                             63-0860407
(State or Other Jurisdiction of      (Primary Standard Industrial     (I.R.S. Employer Identification
Incorporation or Organization)       Classification Code Number)      Number)

                                   --------------------
</TABLE>

               ONE HEALTHSOUTH PARKWAY, BIRMINGHAM, ALABAMA 35243
                                 (205) 967-7116
              (Address, including Zip Code, and Telephone Number,
       including Area Code, of Registrant's Principal Executive Offices)

                              RICHARD M. SCRUSHY
                          CHAIRMAN OF THE BOARD AND
                           CHIEF EXECUTIVE OFFICER
                           HEALTHSOUTH CORPORATION
                           ONE HEALTHSOUTH PARKWAY
                          BIRMINGHAM, ALABAMA 35243
                                (205) 967-7116
          (Name, Address, including Zip Code, and Telephone Number,
                  including Area Code, of Agent for Service)

                                  COPIES TO:

<TABLE>
<CAPTION>
<S>                                             <C>     
          MARK E. EZELL, ESQ                          WILLIAM W. HORTON, ESQ.
    Haskell Slaughter & Young, L.L.C.      Senior Vice President and Corporate Counsel
     1200 AmSouth/Harbert Plaza                       HEALTHSOUTH Corporation
      1901 Sixth Avenue North                         One HealthSouth Parkway
     Birmingham, Alabama 35203                       Birmingham, Alabama 35243
         (205) 251-1000                                    (205) 967-7116

                                   ----------
</TABLE>

   APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From time to
time after this Registration Statement becomes effective.

   If the only  securities  being  registered  on this  Form are  being  offered
pursuant to dividend or interest  reinvestment plans, please check the following
box. [ ]  

   If any of the securities being registered on this Form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]

   If this  Form is filed to  register  additional  securities  for an  offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list  the  Securities  Act  registration  statement  number  of the  earlier
effective registration statement for the same offering. [ ]

   If this Form is a  post-effective  amendment  filed  pursuant  to Rule 462(c)
under the  Securities  Act,  check the following box and list the Securities Act
registration  statement number of the earlier effective  registration  statement
for the same offering. [ ]

   If delivery of the  prospectus  is expected to be made  pursuant to Rule 434,
please check the following box. [ ]

<TABLE>
<CAPTION>


                       CALCULATION OF REGISTRATION FEE
=============================================================================================================================
<S>                                         <C>               <C>                   <C>                     <C>
    TITLE OF EACH                                                PROPOSED MAXIMUM      PROPOSED MAXIMUM
CLASS OF SECURITIES                         AMOUNT TO BE          OFFERING PRICE        AGGREGATE OFFERING      AMOUNT OF
  TO BE REGISTERED                         REGISTERED (1)          PER UNIT (1)            PRICE (1)         REGISTRATION FEE
- -----------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.01 per share ...  223,000 shares             $ 18.25               $ 4,069,750             $ 1,233.26
=============================================================================================================================
</TABLE>

(1) Estimated  solely for the purpose of calculating  the  registration  fee, in
    accordance with Rule 457(c). The average of the high and low prices reported
    by the  New  York  Stock  Exchange  for  the  Common  Stock  of  HEALTHSOUTH
    Corporation on April 22, 1997, was $ 18.25.


   The  Registrant  hereby  amends this  Registration  Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further  Amendment  which  specifically  states  that  this  Registration
Statement shall  thereafter  become effective in accordance with Section 8(a) of
the  Securities  Act of 1933 or until the  Registration  Statement  shall become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.
================================================================================

<PAGE>

                 SUBJECT TO COMPLETION, DATED APRIL 25, 1997


                                  PROSPECTUS
                                      OF
                           HEALTHSOUTH CORPORATION


   THIS PROSPECTUS RELATES TO 223,000 SHARES (THE "SHARES") OF THE COMMON STOCK,
PAR VALUE  $.01 PER SHARE  (THE  "HEALTHSOUTH  COMMON  STOCK"),  OF  HEALTHSOUTH
CORPORATION  (TOGETHER WITH ITS  SUBSIDIARIES,  "HEALTHSOUTH"  OR THE "COMPANY")
BEING  OFFERED  BY THE  SELLING  STOCKHOLDER  IDENTIFIED  HEREIN  (THE  "SELLING
STOCKHOLDER"). THE SELLING STOCKHOLDER ACQUIRED THE SHARES OF HEALTHSOUTH COMMON
STOCK IN CONNECTION WITH THE ACQUISITION BY HEALTHSOUTH OF HEALTH IMAGES, INC. A
DELAWARE  CORPORATION  ("HEALTH  IMAGES"),   ON  MARCH  3,  1997.  SEE  "SELLING
STOCKHOLDER".

                                   ----------

   All  proceeds  from any sales of the Shares by the Selling  Stockholder  will
inure to the benefit of the Selling  Stockholder.  The Company will receive none
of the  proceeds  from the sale of  Shares  which  may be  offered  hereby.  All
expenses of  registration  incurred in connection  herewith,  including fees and
expenses of counsel to the Selling Stockholder,  are being borne by the Company,
and all selling and other expenses  incurred by the Selling  Stockholder will be
borne by the Selling Stockholder.

   The Selling Stockholder has not advised the Company of any specific plans for
the distribution of the Shares covered by this Prospectus, but it is anticipated
that the Shares will be sold from time to time primarily in transactions  (which
may include  block  transactions)  on the New York Stock  Exchange at the market
price  then   prevailing,   although  sales  may  also  be  made  in  negotiated
transactions or otherwise.  The Selling  Stockholder and the brokers and dealers
through  whom sale of the Shares may be made may be deemed to be  "underwriters"
within  the  meaning  of the  Securities  Act of 1933,  as  amended,  and  their
commissions or discounts and other compensation may be regarded as underwriters'
compensation. See "Plan of Distribution".

    THE SECURITIES TO BE ISSUED HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
         SECURITIES AND EXCHANGE COMMISSION (THE "SEC") OR BY ANY STATE
               SECURITIES COMMISSION NOR HAS THE SEC OR ANY STATE
                SECURITIES COMMISSION PASSED UPON THE ACCURACY OR
                        ADEQUACY OF THIS PROSPECTUS. ANY
                        REPRESENTATION TO THE CONTRARY IS
                               A CRIMINAL OFFENSE.

                                   ----------
                THE DATE OF THIS PROSPECTUS IS        , 1997.

[Information   contained  herein  is  subject  to  completion  or  amendment.  A
Registration  Statement  relating  to these  securities  has been filed with the
Securities and Exchange  Commisssion.  These securities may  not be sold nor may
offers to buy be accepted prior to the time the Registration  Statement  becomes
effective.  This  Prospectus  shall  not  constitute  an  offer  to  sell or the
solicitation of an offer to buy nor shall there be any sale of these  securities
in any State in which such offer,  solicitation  or sale would be unlawful prior
to registration or qualification under the securities laws of any such State.]


<PAGE>
                            AVAILABLE INFORMATION

   HEALTHSOUTH  has  filed a  Registration  Statement  on  Form  S-3  under  the
Securities Act of 1933, as amended (the "Securities Act"), with the SEC covering
the  Shares  (including  exhibits  and  amendments  thereto,  the  "Registration
Statement").  As  permitted  by the  rules  and  regulations  of the  SEC,  this
Prospectus omits certain  information  contained in the Registration  Statement.
For further information  pertaining to the securities offered hereby,  reference
is made to the Registration Statement.

   HEALTHSOUTH  is subject to the  information  requirements  of the  Securities
Exchange  Act of 1934,  as  amended  (the  "Exchange  Act"),  and in  accordance
therewith files periodic  reports,  proxy statements and other  information with
the SEC relating to its business,  financial  statements and other matters.  The
Registration  Statement,  as well as such reports,  proxy  statements  and other
information,  may be inspected at the public reference facilities  maintained by
the SEC at Room 1024, 450 Fifth Street, N.W., Judiciary Plaza, Washington,  D.C.
20549 and should be available for inspection and copying at the regional offices
of the SEC located at Seven World Trade Center,  Suite 1300,  New York, New York
10048; 5670 Wilshire Boulevard, 11th Floor, Los Angeles,  California 90036-3648;
and Citicorp  Center,  500 West Madison  Street,  Room 1400,  Chicago,  Illinois
60661-2511.  Copies of such  material  can be  obtained at  prescribed  rates by
writing  to  the  SEC,  Public  Reference  Section,   450  Fifth  Street,  N.W.,
Washington, D.C. 20549. The SEC also maintains a web site that contains reports,
proxy and information statements and other information regarding HEALTHSOUTH and
the Registration Statement.  The address of that web site is http://www.sec.gov.
The HEALTHSOUTH  Common Stock is listed on the New York Stock Exchange,  and the
Registration Statement,  reports, proxy statements and certain other information
filed by  HEALTHSOUTH  should be available for  inspection at the library of the
New York Stock Exchange,  Inc., 20 Broad Street,  7th Floor,  New York, New York
10005.

              INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

   THIS PROSPECTUS  INCORPORATES  DOCUMENTS BY REFERENCE WHICH ARE NOT PRESENTED
HEREIN OR DELIVERED HEREWITH. COPIES OF SUCH REPORTS, PROXY STATEMENTS AND OTHER
INFORMATION  FILED BY HEALTHSOUTH,  OTHER THAN EXHIBITS TO SUCH DOCUMENTS UNLESS
SUCH EXHIBITS ARE SPECIFICALLY  INCORPORATED HEREIN BY REFERENCE,  ARE AVAILABLE
WITHOUT CHARGE, UPON WRITTEN OR ORAL REQUEST,  FROM THE SECRETARY OF HEALTHSOUTH
CORPORATION, ONE HEALTHSOUTH PARKWAY, BIRMINGHAM, ALABAMA 35243, TELEPHONE (205)
967-7116.

   There  are  hereby   incorporated  by  reference  in  this  Prospectus,   and
specifically  made a part hereof,  the following  documents  heretofore filed by
HEALTHSOUTH with the SEC, pursuant to the Exchange Act:

     1. The  Company's  Annual  Report on Form 10-K for the  fiscal  year  ended
  December 31, 1996.

     2. The  Company's  Current  Report  on Form 8-K  filed  February  19,  1997
(relating to the acquisition of Horizon/CMS Healthcare Corporation).

     3. The Company's Current Report on Form 8-K filed March 13, 1997 (reporting
the consummation of the acquisition of Health Images, Inc.).

     4.  The  description  of  the  Company's  capital  stock  contained  in the
  Company's Registration Statement on Form 8-A filed August 26, 1989.


                                        2

<PAGE>



   All documents filed by HEALTHSOUTH  pursuant to Sections 13(a),  13(c), 14 or
15(d) of the  Exchange  Act after the date of this  Prospectus  and prior to the
termination  of any offering  hereunder  shall be deemed to be  incorporated  by
reference into this Prospectus and to be made a part hereof from the date of the
filing of such documents.  Any statement contained in a document incorporated by
reference  herein shall be deemed to be modified or  superseded  for the purpose
hereof  to the  extent  that  a  statement  contained  herein  (or in any  other
subsequently  filed document  which also is  incorporated  by reference  herein)
modifies or supersedes such  statement.  Any statement so modified or superseded
shall  not be deemed to  constitute  a part  hereof,  except as so  modified  or
superseded.

   NO PERSON IS AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATION
NOT CONTAINED IN THIS  PROSPECTUS,  AND, IF GIVEN OR MADE,  SUCH  INFORMATION OR
REPRESENTATION SHOULD NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED.  NEITHER THE
DELIVERY OF THIS PROSPECTUS NOR ANY DISTRIBUTION OF THE SECURITIES TO WHICH THIS
PROSPECTUS RELATES SHALL,  UNDER ANY CIRCUMSTANCES,  CREATE ANY IMPLICATION THAT
THERE HAS BEEN NO CHANGE IN THE INFORMATION  CONCERNING HEALTHSOUTH CONTAINED IN
THIS PROSPECTUS SINCE THE DATE OF SUCH INFORMATION.


   The principal executive offices of HEALTHSOUTH are located at One HealthSouth
Parkway, Birmingham, Alabama 35243 and its telephone number is (205) 967-7116.


                                       3

<PAGE>
                                 RISK FACTORS

   In addition to the other information in this Prospectus, the following should
be considered carefully by potential purchasers of the Shares.

   Regulation.  As a result of the continued  escalation of healthcare costs and
the inability of many individuals to obtain health insurance, numerous proposals
have  been  or may be  introduced  in  the  United  States  Congress  and  state
legislatures  relating to healthcare reform. There can be no assurance as to the
ultimate content, timing or effect of any healthcare reform legislation,  nor is
it possible at this time to estimate the impact of potential legislation,  which
may be material,  on  HEALTHSOUTH.  HEALTHSOUTH is also subject to various other
types of regulation at the federal and state levels,  including, but not limited
to, licensure and certification laws, Certificate of Need laws and laws relating
to financial  relationships  among  providers of healthcare  services,  Medicare
fraud and abuse and physician self-referral.

                                 THE COMPANY

   HEALTHSOUTH  Corporation  ("HEALTHSOUTH"  or the  "Company")  is the nation's
largest  provider of outpatient  and  rehabilitative  healthcare  services.  The
Company  provides these services  through its national network of outpatient and
inpatient  rehabilitation  facilities,  outpatient  surgery centers,  diagnostic
centers,  occupational  medicine  centers,  medical centers and other healthcare
facilities.  The Company  believes  that it provides  patients,  physicians  and
payors with high-quality  healthcare  services at significantly lower costs than
traditional inpatient hospitals.  Additionally,  the Company's national network,
reputation for quality and focus on outcomes has enabled it to secure  contracts
with  national and  regional  managed  care  payors.  At December 31, 1996,  the
Company had over 1,000 patient care locations in 50 states.

   In its  outpatient  and  inpatient  rehabilitation  facilities,  the  Company
provides   interdisciplinary   programs  for  the   rehabilitation  of  patients
experiencing  disability due to a wide variety of physical  conditions,  such as
stroke,   head  injury,   orthopaedic   problems,   neuromuscular   disease  and
sports-related  injuries. The Company's rehabilitation services include physical
therapy,  sports  medicine,  work hardening,  neurorehabilitation,  occupational
therapy,  respiratory  therapy,  speech  language  pathology and  rehabilitation
nursing.  Independent studies have shown that rehabilitation services like those
provided by the Company can save money for payors and employers.

   In addition to its rehabilitation facilities, the Company operates one of the
largest  networks  of  free-standing  outpatient  surgery  centers in the United
States.  The Company's  outpatient  surgery  centers  provide the facilities and
medical support staff necessary for physicians to perform non-emergency surgical
procedures.  While  outpatient  surgery is widely  recognized as generally  less
expensive  than  surgery  performed  in a hospital,  the Company  believes  that
outpatient  surgery  performed at a free-standing  outpatient  surgery center is
generally less expensive than hospital-based  outpatient surgery.  Approximately
80% of the Company's  surgery center facilities are located in markets served by
its  rehabilitative   service   facilities,   enabling  the  Company  to  pursue
opportunities for cross-referrals.

   Over the last two  years,  the  Company  has  completed  several  significant
acquisitions  in the  rehabilitation  business and has expanded into the surgery
center,  diagnostic and occupational  medicine businesses.  The Company believes
that these  acquisitions  complement its  historical  operations and enhance its
market  position.  The Company  further  believes  that its  expansion  into the
outpatient surgery,  diagnostic and occupational medicine businesses provides it
with  platforms  for  future  growth.  The  Company  is  continually  evaluating
potential acquisitions in the outpatient and rehabilitative  healthcare services
industry.

                               USE OF PROCEEDS

   All  proceeds  from any sales of the Shares by the Selling  Stockholder  will
inure to the benefit of the Selling  Stockholder.  The Company will receive none
of the proceeds from the sale of Shares offered hereby.

                                        4

<PAGE>

                             SELLING STOCKHOLDER


   The Shares of HEALTHSOUTH  Common Stock were acquired by Robert D. Carl, III,
the Selling Stockholder,  pursuant to the exercise of a warrant issued by Health
Images,  Inc.  ("Health  Images"),  which was assumed by HEALTHSOUTH in a merger
transaction  (the "Merger") on March 3, 1997, in which a wholly owned subsidiary
of HEALTHSOUTH was merged with and into Health Images.  The Selling  Stockholder
was previously  the Chairman,  President and Chief  Executive  Officer of Health
Images.  The Selling  Stockholder is acting as principal for his own account and
has registered for resale the entire amount of HEALTHSOUTH Common Stock obtained
by him through the exercise of such warrant,  although he retains  discretion to
sell less than such entire amount.


   The  Selling  Stockholder  is not an  executive  officer or  director  of the
HEALTHSOUTH.  The total number of Shares  available  for sale  hereunder is less
than .001% of the total  outstanding  Common  Stock of the  Company at April 23,
1997.


                             PLAN OF DISTRIBUTION

   The Shares of HEALTHSOUTH  Common Stock may be offered and sold by or for the
account of the Selling Stockholder from time to time as market conditions permit
on The New York  Stock  Exchange,  or  otherwise,  at prices  and on terms  then
prevailing or in negotiated transactions.  Some or all of the Shares may be sold
by one or more of the following methods,  without limitation:  (a) a block trade
in which a broker or dealer so engaged will attempt to sell the shares as agent,
but may position  and resell a portion of the block as  principal to  facilitate
the transaction;  (b) purchases by a broker or dealer (including a market maker)
as  principal  and resale by such broker or dealer for its  account  pursuant to
this Prospectus;  (c) ordinary brokerage  transactions and transactions in which
the  broker  solicits  purchasers;  and (d)  face-to-face  transactions  between
sellers and purchasers without a broker-dealer.  In effecting sales,  brokers or
dealers  engaged by the Selling  Stockholder  may  arrange for other  brokers or
dealers to  participate.  Such  brokers or dealers  may receive  commissions  or
discounts from the Selling Stockholder in amounts to be negotiated. Such brokers
and dealers and any other  participating  brokers or dealers may be deemed to be
"underwriters" within the meaning of the Securities Act, in connection with such
sales.

   Upon the  Selling  Stockholder's  notifying  the  Company  that any  material
arrangement  has been entered into with a  broker-dealer  for the sale of Shares
through a cross or block trade,  a supplemental  prospectus  will be filed under
Rule  424(c)  under  the  Securities   Act,   setting  forth  the  name  of  the
participating  broker-dealer(s),  the  number of Shares  involved,  the price at
which such Shares were sold by the Selling Stockholder,  the commissions paid or
discounts  or   concessions   allowed  by  the  Selling   Stockholder   to  such
broker-dealer(s),  and  where  applicable,  that such  broker-dealer(s)  did not
conduct any investigation to verify the information set out in the Prospectus.

                                   EXPERTS

   The consolidated financial statements and schedule of HEALTHSOUTH at December
31, 1996 and 1995,  and for each of the three years in the period ended December
31, 1996,  appearing  in  HEALTHSOUTH's  Annual  Report (Form 10-K) for the year
ended  December  31, 1996,  have been audited by Ernst & Young LLP,  independent
auditors, as set forth in their report thereon incorporated herein by reference.
Such consolidated  financial  statements and schedule are incorporated herein by
reference in reliance  upon such report given upon the authority of such firm as
experts in accounting and auditing.

                                LEGAL MATTERS


   The validity of the shares of HEALTHSOUTH  Common Stock issued to the Selling
Stockholder  has been  passed upon by Haskell  Slaughter & Young, L.L.C. 


                                        5

<PAGE>


                                   PART II
                    INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

   The  following  table sets forth the  estimated  expenses  to be  incurred in
connection with the distribution of the securities  registered  hereby. All such
expenses shall be borne by the Company.

     Registration fee under the Securities Act of 1933  ...      $  1,233.26
     New York Stock Exchange listing fee ..................           780.00
     Printing expenses ....................................        10,000.00
     Legal fees and expenses ..............................         5,000.00
     Accounting services ..................................         5,000.00
     Miscellaneous ........................................           500.00
                                                            ----------
          Total ...........................................      $ 22,513.26
                                                            ==========

ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

   Section  102(b)(7) of the Delaware  General  Corporation  Law ("DGCL") grants
corporations  the right to limit or eliminate  the  personal  liability of their
directors in certain  circumstances  in accordance with  provisions  therein set
forth.  Article Nine of the HEALTHSOUTH  Restated  Certificate of  Incorporation
filed in the Office of the  Secretary of the State of Delaware on March 13, 1997
(the "HEALTHSOUTH  Certificate"),  contains a provision eliminating or limiting
director  liability to HEALTHSOUTH  and its  stockholders  for monetary  damages
arising  from acts or omissions in the  director's  capacity as a director.  The
provision  does not,  however,  eliminate or limit the  personal  liability of a
director (i) for any breach of such director's duty of loyalty to HEALTHSOUTH or
its stockholders,  (ii) for acts or omissions not in good faith or which involve
intentional  misconduct or a knowing  violation of law, (iii) under the Delaware
statutory  provision  making  directors  personally  liable,  under a negligence
standard, for unlawful dividends or unlawful stock purchases or redemptions,  or
(iv) for any transaction  from which the director  derived an improper  personal
benefit.  This  provision  offers persons who serve on the Board of Directors of
HEALTHSOUTH  protection  against  awards  of  monetary  damages  resulting  from
breaches of their duty of care (except as indicated  above). As a result of this
provision,  the ability of HEALTHSOUTH or a stockholder  thereof to successfully
prosecute  an  action  against  a  director  for a breach of his duty of care is
limited.  However,  the provision does not affect the  availability of equitable
remedies such as an injunction or rescission  based upon a director's  breach of
his duty of care. The SEC has taken the position that the provision will have no
effect on claims arising under the Federal securities laws.

   Section  145 of the DGCL grants  corporations  the right to  indemnify  their
directors,  officers,  employees  and agents in accordance  with the  provisions
therein set forth. Article Nine of the HEALTHSOUTH Certificate and Article IX of
the HEALTHSOUTH Bylaws provide for mandatory  indemnification rights, subject to
limited exceptions, to any director,  officer, employee, or agent of HEALTHSOUTH
who, by reason of the fact that he or she is a director,  officer,  employee, or
agent of  HEALTHSOUTH,  is involved in a legal  proceeding  of any nature.  Such
indemnification  rights  include  reimbursement  for  expenses  incurred by such
director,  officer,  employee,  or agent in advance of the final  disposition of
such proceeding in accordance with the applicable provisions of the DGCL.

   HEALTHSOUTH  has entered into  agreements  with all of its  Directors and its
executive  officers  pursuant to which  HEALTHSOUTH has agreed to indemnify such
Directors and executive officers against liability incurred by them by reason of
their services of a Director to the fullest extent  allowable  under  applicable
law.

                                      II-1

<PAGE>



ITEM 16. EXHIBITS.

   Exhibits:

   EXHIBIT
     NO.                 DESCRIPTION
    ---                  -----------

(5)          Opinion of Haskell Slaughter & Young, L.L.C., as to the legality of
             the  shares  of  HEALTHSOUTH  Common  Stock  issued  in  connection
             herewith.

(10)         Warrant  Agreement  and  Certificate,  dated  May  19,1987,  by and
             between  Health  Images,  Inc.,  and Robert D. Carl,  III, filed as
             Exhibit 10(f)(ii) to Health Images,  Inc.'s Registration  Statement
             on Form S-1  (Registration  No.  33-14437)  is hereby  incorporated
             herein by reference.

(23)-1       Consent  of  Ernst & Young  LLP.  See  page  immediately  following
             signature pages to the Registration Statement.

(23)-2       Consent of  Haskell  Slaughter  & Young,  L.L.C.  (included  in the
             opinion filed as Exhibit (5)).

(24)         Powers of Attorney.  See signature pages.

ITEM 17. UNDERTAKINGS.

   The undersigned registrant hereby undertakes:

   (1) To file,  during any period in which  offers or sales are being  made,  a
post-effective amendment to this registration statement;

       (iii)   to include any material  information  with respect to the plan of
               distribution  not  previously   disclosed  in  this  registration
              

 statement  or any  material  change  to such  information  in the
               registration statement.

   (2) That, for the purpose of determining  any liability  under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

   (3) To remove from registration by means of a post-effective amendment any of
the securities  being  registered  which remain unsold at the termination of the
offering.

   (4) That, for the purpose of determining  any liability  under the Securities
Act of 1933, each filing of the  registrant's  annual report pursuant to section
13(a)  or  section  15(d)  of the  Securities  Exchange  Act  of  1934  that  is
incorporated by reference in the registration  statement shall be deemed to be a
new registration  statement relating to the securities offered therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.




















                                      II-2

<PAGE>



                                  SIGNATURES

   Pursuant to the  requirements  of the  Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds  to  believe  that it meets  all the
requirements  for  filing  on Form S-3 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Birmingham, State of Alabama, on April 25, 1997.

                                             HEALTHSOUTH Corporation


                                             By  /s/ RICHARD M. SCRUSHY
                                                 -------------------------------
                                                     Richard M. Scrushy
                                                  Chairman of the Board and
                                                   Chief Executive Officer

   KNOW ALL MEN BY THESE  PRESENTS,  that each person  whose  signature  appears
below  constitutes and appoints  Richard M. Scrushy and Aaron Beam, Jr. and each
of them, his attorney-in-fact with powers of substitution for him in any and all
capacities,  to  sign  any  amendments,   supplements,  subsequent  registration
statements  relating  to the  offering  to  which  this  Registration  Statement
relates, or other instruments he deems necessary or appropriate, and to file the
same, with exhibits thereto, and other documents in connection  therewith,  with
the Securities and Exchange Commission, hereby ratifying and confirming all that
said  attorney-in-fact  or his  substitute  may do or cause to be done by virtue
hereof.

   Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed below by the following  persons in the  capacities and
on the dates indicated.

         SIGNATURE                        TITLE                       DATE
         ---------                        -----                       ----
                                 
  /s/ RICHARD M. SCRUSHY           Chairman of the Board          April 25, 1997
- ---------------------------     and Chief Executive Officer 
      Richard M. Scrushy              and Director  

                                                               
    /s/ AARON BEAM, JR.         Executive Vice President and      April 25, 1997
- ---------------------------        Chief Financial Officer                   
        Aaron Beam, Jr.     
                                                       
                                               
   /s/ WILLIAM T. OWENS             Senior Vice President         April 25, 1997
- ---------------------------       and Controller (Principal  
      William T. Owens               Accounting Officer)

                                                                 
   /s/ JAMES P. BENNETT                  Director                 April 25, 1997
- ---------------------------
       James P. Bennett  

                                                                                
   /s/ ANTHONY J. TANNER                 Director                 April 25, 1997
- ---------------------------
       Anthony J. Tanner  

                                                                              
     /s/ P. DARYL BROWN                  Director                 April 25, 1997
- ---------------------------
         P. Daryl Brown     

                                                                               
/s/ PHILLIP C. WATKINS, M.D.             Director                 April 25, 1997
- ----------------------------
    Phillip C. Watkins, M.D.  

                                                                        
   /s/ GEORGE H. STRONG                  Director                 April 25, 1997
- ---------------------------
       George H. Strong 

                                                                                
    /s/ C. SAGE GIVENS                   Director                 April 25, 1997
- ---------------------------
        C. Sage Givens                                                          
                                                            
                                      II-3
<PAGE>
         SIGNATURE                        TITLE                       DATE
         ---------                        -----                       ----

/s/ CHARLES W. NEWHALL III                Director                April 25, 1997
- ---------------------------                                                     
    Charles W. Newhall III                                                      
                                                                                
                                                                                
   /s/ LARRY R. HOUSE                     Director                April 25, 1997
- ---------------------------                                                     
      Larry R. House                                                            
                                                                                
                                                                                
   /s/ JOHN S. CHAMBERLIN                 Director                April 25, 1997
- ---------------------------                                                     
       John S. Chamberlin                                                       
                                                                                
                                                                                
  /s/ RICHARD F. CELESTE                  Director                April 25, 1997
- ---------------------------                                                     
      Richard F. Celeste                                                        
                                                                                
                                                                                
    /s/ JOEL C. GORDON                    Director                April 25, 1997
- ---------------------------                                                     
        Joel C. Gordon                                                          
                                                                                
                                                                                
  /s/ RAYMOND J. DUNN, III                Director                April 25, 1997
- ---------------------------                                                     
      Raymond J. Dunn, III                                   


                                   

                                      II-4

                                                                       EXHIBIT 5



Haskell Slaughter & Young, L.L.C.
1200 AmSouth/Harbert Plaza
1901 Sixth Avenue North
Birmingham, Alabama  35203



April 25, 1997



HEALTHSOUTH Corporation
One HealthSouth Parkway
Birmingham, Alabama 35243



          RE:            HEALTHSOUTH CORPORATION
                    REGISTRATION STATEMENT ON FORM S-3

Gentlemen:

         We have  served as  counsel  for  HEALTHSOUTH  Corporation,  a Delaware
corporation  (the  "Company"),  in connection  with the  registration  under the
Securities  Act of 1933,  as amended,  of an  aggregate  of 223,000  shares (the
"Shares") of the Company's authorized Common Stock, par value $.01 per share, to
be issued pursuant to that certain Warrant  Agreement and Certificate  dated May
19, 1987 (the "Warrant  Agreement"),  between Health Images, Inc., and Robert D.
Carl,  III,  which  registration  is being  effected  pursuant to the  Company's
Registration   Statement  on  Form  S-3  relating  thereto  (the   "Registration
Statement").  This opinion is furnished to you pursuant to the  requirements  of
Form S-3.

         In connection with this opinion, we have examined and are familiar with
originals or copies  (certified or otherwise  identified to our satisfaction) of
such  documents,  corporate  records  and  other  instruments  relating  to  the
incorporation of the Company and to the authorization and issuance of the Shares
as we have deemed necessary and appropriate.

         Based  upon  the   foregoing,   and   having   regard  for  such  legal
considerations we have deemed relevant, it is our opinion that:

         1. The Shares have been duly authorized.

<PAGE>
HEALTHSOUTH Corporation
April 25, 1997
Page 2





         2. Upon issuance,  sale and delivery of the Shares as  contemplated  in
the Registration Statement and the Warrant Agreement, the Shares will be legally
issued, fully paid and nonassessable.

         We hereby consent to the reference to our Firm under the heading "Legal
Matters" in the Prospectus which forms a part of the Registration Statement, and
to the filing of this opinion as an Exhibit thereto.

                                               Very truly yours,

                                               HASKELL SLAUGHTER & YOUNG, L.L.C.



                                               By        /s/ MARK EZELL
                                                 -------------------------------
                                                             Mark Ezell



                                                                  EXHIBIT (23)-1

                          CONSENT OF ERNST & YOUNG LLP
                              INDEPENDENT AUDITORS

We  consent to the  reference  to our firm under the  caption  "Experts"  in the
Registration  Statement  (Form  S-3,  No.  333-  )  and  related  Prospectus  of
HEALTHSOUTH  Corporation for the  registration of shares of its common stock and
to the incorporation by reference therein of our report dated February 24, 1997,
except  for the  first  paragraph  of Note 15, as to which the date is March 12,
1997,  with respect to the  consolidated  financial  statements  and schedule of
HEALTHSOUTH  Corporation  included in its Annual Report (Form 10-K) for the year
ended December 31, 1996, filed with the Securities and Exchange Commission.

Birmingham, Alabama
April 25, 1997

                             



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission